Human patients with mutations in ATP6V1B1 develop distal renal tubule acidosis (dRTA) and suffer from nephrocalcinosis [30], while mice with Atp6v1b1 deletion show urine alkalinization with no systemic acidosis or nephrocalcinosis. Here, ATP6V1B1 is linked to nephrocalcinosis.